Diabetes and cardiovascular disease: Changing the focus from glycemic control to improving long-term survival

American Journal of Cardiology

Volumn 110, Issue SUPPL. 9, 2012, Pages 58B-68B

  Wang, Cecilia C Low ^a,b   Reusch, Jane E B ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; ATORVASTATIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RAMIPRIL; SIMVASTATIN; TRIACYLGLYCEROL;

ALBUMINURIA; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART FAILURE; HUMAN; HYPERTENSION; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LIFESTYLE MODIFICATION; MICROALBUMINURIA; MORTALITY; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PERIPHERAL VASCULAR DISEASE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SURVIVAL; TREATMENT OUTCOME; VASCULAR DISEASE;

EID: 84867562091     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.08.036     Document Type: Article

References (85)

1. W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, E.A. Walker, D.M. Nathan Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 2002 393 403
2. X.R. Pan, G.W. Li, Y.H. Hu, J.X. Wang, W.Y. Yang, Z.X. An, Z.X. Hu, J. Lin, J.Z. Xiao, H.B. Cao Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study Diabetes Care 20 1997 537 544
3. S.L. Edelstein, W.C. Knowler, R.P. Bain, R. Andres, E.L. Barrett-Connor, G.K. Dowse, S.M. Haffner, D.J. Pettitt, J.D. Sorkin, D.C. Muller, V.R. Collins, R.F. Hamman Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies Diabetes 46 1997 701 710
4. W.C. Knowler, K.M. Narayan, R.L. Hanson, R.G. Nelson, P.H. Bennett, J. Tuomilehto, B. Schersten, D.J. Pettitt Preventing non-insulin-dependent diabetes Diabetes 44 1995 483 488
5. O.H. Franco, E.W. Steyerberg, F.B. Hu, J. Mackenbach, W. Nusselder Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease Arch Intern Med 167 2007 1145 1151
6. G. Roglic, N. Unwin, P.H. Bennett, C. Mathers, J. Tuomilehto, S. Nag, V. Connolly, H. King The burden of mortality attributable to diabetes: realistic estimates for the year 2000 Diabetes Care 28 2005 2130 2135
7. K.N. Barnett, S.A. Ogston, M.E. McMurdo, A.D. Morris, J.M. Evans A 12-year follow-up study of all-cause and cardiovascular mortality among 10,532 people newly diagnosed with Type 2 diabetes in Tayside, Scotland Diabet Med 27 2010 1124 1129
8. C.L. Li, H.Y. Chang, Y.I. Shyu The excess mortality risk of diabetes associated with functional decline in older adults: results from a 7-year follow-up of a nationwide cohort in Taiwan BMC Public Health 11 2011 953
9. P. Gaede, H. Lund-Andersen, H.H. Parving, O. Pedersen Effect of a multifactorial intervention on mortality in type 2 diabetes N Engl J Med 358 2008 580 591
10. J.B. Redmon, A.G. Bertoni, S. Connelly, P.A. Feeney, S.P. Glasser, H. Glick, F. Greenway, L.A. Hesson, M.S. Lawlor, M. Montez, B. Montgomery Effect of the look AHEAD study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with type 2 diabetes Diabetes Care 33 2010 1153 1158
11. W.J. Rejeski, E.H. Ip, A.G. Bertoni, G.A. Bray, G. Evans, E.W. Gregg, Q. Zhang Lifestyle change and mobility in obese adults with type 2 diabetes N Engl J Med 366 2012 1209 1217
12. C.S. Fox, M.J. Pencina, P.W. Wilson, N.P. Paynter, R.S. Vasan, R.B. D'Agostino Sr Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study Diabetes Care 31 2008 1582 1584
13. F.B. Hu, M.J. Stampfer, S.M. Haffner, C.G. Solomon, W.C. Willett, J.E. Manson Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes Diabetes Care 25 2002 1129 1134
14. J. Stamler, O. Vaccaro, J.D. Neaton, D. Wentworth Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial Diabetes Care 16 1993 434 444
15. S.M. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, M. Laakso Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 1998 229 234
16. A.P. Kengne, A. Patel, M. Marre, F. Travert, M. Lievre, S. Zoungas, J. Chalmers, S. Colagiuri, D.E. Grobbee, P. Hamet Contemporary model for cardiovascular risk prediction in people with type 2 diabetes Eur J Cardiovasc Prev Rehabil 18 2011 393 398
17. P. Gaede, H. Lund-Andersen, H.H. Parving, O. Pedersen Effect of a multifactorial intervention on mortality in type 2 diabetes N Engl J Med 358 2008 580 591
18. J.M. Sprafka, G.L. Burke, A.R. Folsom, P.G. McGovern, L.P. Hahn Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival: the Minnesota Heart Survey Diabetes Care 14 1991 537 543
19. J. Kuusisto, L. Mykkanen, K. Pyorala, M. Laakso NIDDM and its metabolic control predict coronary heart disease in elderly subjects Diabetes 43 1994 960 967
20. G.A. Nichols, T.A. Hillier, J.R. Erbey, J.B. Brown Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors Diabetes Care 24 2001 1614 1619
21. K. Malmberg, S. Yusuf, H.C. Gerstein, J. Brown, F. Zhao, D. Hunt, L. Piegas, J. Calvin, M. Keltai, A. Budaj Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry Circulation 102 2000 1014 1019
22. D.L. Dries, N.K. Sweitzer, M.H. Drazner, L.W. Stevenson, B.J. Gersh Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction J Am Coll Cardiol 38 2001 421 428
23. J.E. Reusch, C.C. Wang Cardiovascular disease in diabetes: where does glucose fit in? J Clin Endocrinol Metab 96 2011 2367 2376
24. J.E. Reusch, B.B. Draznin Atherosclerosis in diabetes and insulin resistance Diabetes Obes Metab 9 2007 455 463
25. C.C. Wang, M.L. Goalstone, B. Draznin Molecular mechanisms of insulin resistance that impact cardiovascular biology Diabetes 53 2004 2735 2740
26. S. Sitia, L. Tomasoni, F. Atzeni, G. Ambrosio, C. Cordiano, A. Catapano, S. Tramontana, F. Perticone, P. Naccarato, P. Camici From endothelial dysfunction to atherosclerosis Autoimmun Rev 9 2010 830 834
27. A. Otsuka, K. Azuma, T. Iesaki, F. Sato, T. Hirose, T. Shimizu, Y. Tanaka, H. Daida, R. Kawamori, H. Watada Temporary hyperglycaemia provokes monocyte adhesion to endothelial cells in rat thoracic aorta Diabetologia 48 2005 2667 2674
28. A. Pandolfi, A. Giaccari, C. Cilli, M.M. Alberta, L. Morviducci, E.A. De Filippis, A. Buongiorno, G. Pellegrini, F. Capani, A. Consoli Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat Acta Diabetol 38 2001 71 76
29. C.J. Zuurbier, C. Demirci, A. Koeman, H. Vink, C. Ince Short-term hyperglycemia increases endothelial glycocalyx permeability and acutely decreases lineal density of capillaries with flowing red blood cells J Appl Physiol 99 2005 1471 1476
30. T. Velusamy, S.K. Jain Effects of high glucose and ketosis (acetoacetate, ss-hydroxybutyrate) on PAI-1 secretion in human umbilical vascular endothelial cells Clin Appl Thromb Hemost 17 2011 288 292
31. T. Inoguchi, H.Y. Yu, M. Imamura, M. Kakimoto, T. Kuroki, T. Maruyama, H. Nawata Altered gap junction activity in cardiovascular tissues of diabetes Med Electron Microsc 34 2001 86 91
32. A. Makino, O. Platoshyn, J. Suarez, J.X. Yuan, W.H. Dillmann Downregulation of connexin40 is associated with coronary endothelial cell dysfunction in streptozotocin-induced diabetic mice Am J Physiol Cell Physiol 295 2008 C221 C230
33. A. El-Osta, D. Brasacchio, D. Yao, A. Pocai, P.L. Jones, R.G. Roeder, M.E. Cooper, M. Brownlee Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia J Exp Med 205 2008 2409 2417
34. L. Meng, J. Park, Q. Cai, L. Lanting, M.A. Reddy, R. Natarajan Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiation Am J Physiol Heart Circ Physiol 298 2010 H736 H745
35. K. Tanaka, D. Nagata, Y. Hirata, Y. Tabata, R. Nagai, M. Sata Augmented angiogenesis in adventitia promotes growth of atherosclerotic plaque in apolipoprotein E-deficient mice Atherosclerosis 215 2011 366 373
36. P.R. Moreno, V. Fuster New aspects in the pathogenesis of diabetic atherothrombosis J Am Coll Cardiol 44 2004 2293 2300
37. M.W. Majesky, X.R. Dong, V. Hoglund, G. Daum, W.M. Mahoney Jr The adventitia: a progenitor cell niche for the vessel wall Cells Tissues Organs 195 2012 73 81
38. R. Kietadisorn, R.P. Juni, A.L. Moens Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities Am J Physiol Endocrinol Metab 302 2012 E481 E495
39. D. Levy, M.G. Larson, R.S. Vasan, W.B. Kannel, K.K. Ho The progression from hypertension to congestive heart failure JAMA 275 1996 1557 1562
40. S.G. de, R.B. Devereux, M. Chinali, E.T. Lee, J.M. Galloway, A. Barac, J.A. Panza, B.V. Howard Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study J Hypertens 28 2010 353 360
41. A.M. Shah, H. Uno, L. Kober, E.J. Velazquez, A.P. Maggioni, M.R. MacDonald, M.C. Petrie, J.J. McMurray, R.M. Califf, M.A. Pfeffer, S.D. Solomon The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction Eur J Heart Fail 12 2010 1229 1237
42. M.K. Rutter, H. Parise, E.J. Benjamin, D. Levy, M.G. Larson, J.B. Meigs, R.W. Nesto, P.W. Wilson, R.S. Vasan Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study Circulation 107 2003 448 454
43. M. Klapholz, M. Maurer, A.M. Lowe, F. Messineo, J.S. Meisner, J. Mitchell, J. Kalman, R.A. Phillips, R. Steingart, E.J. Brown Jr Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry J Am Coll Cardiol 43 2004 1432 1438
44. R.B. Devereux, M.J. Roman, M. Paranicas, M.J. O'Grady, E.T. Lee, T.K. Welty, R.R. Fabsitz, D. Robbins, E.R. Rhoades, B.V. Howard Impact of diabetes on cardiac structure and function: the strong heart study Circulation 101 2000 2271 2276
45. R. Dhingra, R.S. Vasan Diabetes and the risk of heart failure Heart Fail Clin 8 2012 125 133
46. R. Harmancey, H. Taegtmeyer The complexities of diabetic cardiomyopathy: lessons from patients and animal models Curr Diab Rep 8 2008 243 248
47. M. Burgmaier, S. Sen, F. Philip, C.R. Wilson, C.C. Miller III, M.E. Young, H. Taegtmeyer Metabolic adaptation follows contractile dysfunction in the heart of obese Zucker rats fed a high-fat "Western" diet Obesity (Silver Spring) 18 2010 1895 1901
48. K.J. Nadeau, J.G. Regensteiner, T.A. Bauer, M.S. Brown, J.L. Dorosz, A. Hull, P. Zeitler, B. Draznin, J.E. Reusch Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function J Clin Endocrinol Metab 95 2010 513 521
49. K.J. Nadeau, P.S. Zeitler, T.A. Bauer, M.S. Brown, J.L. Dorosz, B. Draznin, J.E. Reusch, J.G. Regensteiner Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity J Clin Endocrinol Metab 94 2009 3687 3695
50. J. Blacher, A.D. Protogerou, M.E. Safar Large artery stiffness and antihypertensive agents Curr Pharm Des 11 2005 3317 3326
51. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
52. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
53. D.M. Nathan, P.A. Cleary, J.Y. Backlund, S.M. Genuth, J.M. Lachin, T.J. Orchard, P. Raskin, B. Zinman Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes N Engl J Med 353 2005 2643 2653
54. R.R. Holman, S.K. Paul, M.A. Bethel, D.R. Matthews, H.A. Neil 10-year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 359 2008 1577 1589
55. H.C. Gerstein, M.E. Miller, R.P. Byington, D.C. Goff Jr, J.T. Bigger, J.B. Buse, W.C. Cushman, S. Genuth, F. Ismail-Beigi, R.H. Grimm Jr Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2008 2545 2559
56. A. Patel, S. MacMahon, J. Chalmers, B. Neal, L. Billot, M. Woodward, M. Marre, M. Cooper, P. Glasziou, D. Grobbee Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2008 2560 2572
57. W. Duckworth, C. Abraira, T. Moritz, D. Reda, N. Emanuele, P.D. Reaven, F.J. Zieve, J. Marks, S.N. Davis, R. Hayward VADT Investigators Glucose control and vascular complications in veterans with type 2 diabetes N Engl J Med 360 2009 129 139
58. M.E. Miller, D.E. Bonds, H.C. Gerstein, E.R. Seaquist, R.M. Bergenstal, J. Calles-Escandon, R.D. Childress, T.E. Craven, R.M. Cuddihy, G. Dailey The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study BMJ 340 2010 b5444
59. D.E. Bonds, M.E. Miller, R.M. Bergenstal, J.B. Buse, R.P. Byington, J.A. Cutler, R.J. Dudl, F. Ismail-Beigi, A.R. Kimel, B. Hoogwerf The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study BMJ 340 2010 b4909
60. J. Calles-Escandon, L.C. Lovato, D.G. Simons-Morton, D.M. Kendall, R. Pop-Busui, R.M. Cohen, D.E. Bonds, V.A. Fonseca, F. Ismail-Beigi, M.A. Banerji, A. Failor, B. Hamilton Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial Diabetes Care 33 2010 721 727
61. M.C. Riddle, W.T. Ambrosius, D.J. Brillon, J.B. Buse, R.P. Byington, R.M. Cohen, D.C. Goff Jr, S. Malozowski, K.L. Margolis, J.L. Probstfield, A. Schnall, E.R. Seaquist Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial Diabetes Care 33 2010 983 990
62. H.C. Gerstein, M.E. Miller, S. Genuth, F. Ismail-Beigi, J.B. Buse, D.C. Goff Jr, J.L. Probstfield, W.C. Cushman, H.N. Ginsberg, J.T. Bigger Long-term effects of intensive glucose lowering on cardiovascular outcomes N Engl J Med 364 2011 818 828
63. S. Genuth, F. Ismail-Beigi Clinical implications of the ACCORD trial J Clin Endocrinol Metab 97 2012 41 48
64. T. Terry, K. Raravikar, N. Chokrungvaranon, P.D. Reaven Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT Curr Cardiol Rep 14 2012 79 88
65. ADA Standards of medical care in diabetes-2012 Diabetes Care 35 suppl 1 2012 S11 S63
66. S.E. Inzucchi, R.M. Bergenstal, J.B. Buse, M. Diamant, E. Ferrannini, M. Nauck, A.L. Peters, A. Tsapas, R. Wender, D.R. Matthews Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care 65 2012 1364 1379
67. K. Pyorala, T.R. Pedersen, J. Kjekshus, O. Faergeman, A.G. Olsson, G. Thorgeirsson Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) Diabetes Care 20 1997 614 620
68. H.M. Colhoun, D.J. Betteridge, P.N. Durrington, G.A. Hitman, H.A. Neil, S.J. Livingstone, M.J. Thomason, M.I. Mackness, V. Charlton-Menys, J.H. Fuller Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial Lancet 364 2004 685 696
69. R.H. Knopp, M. d'Emden, J.G. Smilde, S.J. Pocock Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN) Diabetes Care 29 2006 1478 1485
70. A. Keech, D. Colquhoun, J. Best, A. Kirby, R.J. Simes, D. Hunt, W. Hague, E. Beller, M. Arulchelvam, J. Baker, A. Tonkin Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial Diabetes Care 26 2003 2713 2721
71. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
72. R. Collins, J. Armitage, S. Parish, P. Sleigh, R. Peto MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial Lancet 361 2003 2005 2016
73. UK Prospective Diabetes Study Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ 317 1998 703 713
74. J.D. Curb, S.L. Pressel, J.A. Cutler, P.J. Savage, W.B. Applegate, H. Black, G. Camel, B.R. Davis, P.H. Frost, N. Gonzalez Systolic Hypertension in the Elderly Program Cooperative Research Group Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension JAMA 276 1996 1886 1892
75. J.I. Barzilay, B.R. Davis, J. Bettencourt, K.L. Margolis, D.C. Goff Jr, H. Black, G. Habib, A. Ellsworth, R.W. Force, T. Wiegmann, J.O. Ciocon, J.N. Basile Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study J Clin Hypertens (Greenwich) 6 2004 116 125
76. J. Ostergren, N.R. Poulter, P.S. Sever, B. Dahlof, H. Wedel, G. Beevers, M. Caulfield, R. Collins, S.E. Kjeldsen, A. Kristinsson The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes J Hypertens 26 2008 2103 2111
77. W.C. Cushman, G.W. Evans, R.P. Byington, D.C. Goff Jr, R.H. Grimm Jr, J.A. Cutler, D.G. Simons-Morton, J.N. Basile, M.A. Corson, J.L. Probstfield Effects of intensive blood-pressure control in type 2 diabetes mellitus N Engl J Med 362 2010 1575 1585
78. H. Ibsen, M.H. Olsen, K. Wachtell, K. Borch-Johnsen, L.H. Lindholm, C.E. Mogensen, B. Dahlof, S.M. Snapinn, Y. Wan, P.A. Lyle Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study Diabetes Care 29 2006 595 600
79. S. Araki, M. Haneda, D. Koya, H. Hidaka, T. Sugimoto, M. Isono, K. Isshiki, M. Chin-Kanasaki, T. Uzu, A. Kashiwagi Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes Diabetes 56 2007 1727 1730
80. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, G. Dagenais Heart Outcomes Prevention Evaluation Study Investigators Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients N Engl J Med 342 2000 145 153
81. Heart Outcomes Prevention Evaluation Study Investigators Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy Lancet 355 2000 253 259
82. G. Hu, P. Jousilahti, N.C. Barengo, Q. Qiao, T.A. Lakka, J. Tuomilehto Physical activity, cardiovascular risk factors, and mortality among Finnish adults with diabetes Diabetes Care 28 2005 799 805
83. D.H. Ryan, M.A. Espeland, G.D. Foster, S.M. Haffner, V.S. Hubbard, K.C. Johnson, S.E. Kahn, W.C. Knowler, S.Z. Yanovski Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes Control Clin Trials 24 2003 610 628
84. R.R. Wing Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial Arch Intern Med 170 2010 1566 1575
85. P. Gaede, P. Vedel, N. Larsen, G.V. Jensen, H.H. Parving, O. Pedersen Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes N Engl J Med 348 2003 383 393